|Molecular Vision 2006;
Received 28 June 2005 | Accepted 20 April 2006 | Published 26 September 2006
Enhanced oligonucleotide delivery to mouse retinal cells using iontophoresis
Charlotte Andrieu-Soler,1 Marc Doat,1 Mounia
Halhal,1 Nicole Keller,1 Laurent Jonet,1 David
(The first two authors contributed equally to this publication)
1INSERM, U598, Paris, France; 2Hadassah Hebrew University Hospital, Jerusalem, Israel; 3Rothschild Foundation of Paris, Paris, France
Correspondence to: Francine Behar-Cohen, INSERM U598, Institut Biomédical des Cordeliers, 15 rue de l'Ecole de Médecine, 75006 Paris, France; Phone: 331 40 46 78 46; FAX: 331 40 46 78 55; email: firstname.lastname@example.org
Purpose: To study the combination of oligodeoxynucleotides (ODNs) intravitreous injection and saline transpalpebral iontophoresis on the delivery of ODNs to photoreceptors in the newborn rd1/rd1 mice.
Methods: Cathodal or anodal transpalpebral iontophoresis (1.43 mA/cm2 for 5 min) was applied to eyes of postnatal day 7 (PN7) rd1/rd1 mice immediately before the intravitreous injection of ODNs. The effect of cathodal iontophoresis after ODNs injection was also evaluated. The influence of current intensity (0.5, 1.5, and 2.5 mA) was assayed with cathodal iontophoresis performed prior to ODNs injection. The duration of current-induced facilitation of ODNs delivery to photoreceptors was evaluated for 6 h following iontophoresis. One group of control eyes received cathodal iontophoresis prior to the intravitreous injection of phosphate buffered saline (PBS) or hexachlorofluorescein (Hex). The second control group received ODN or Hex intravitreous injection without iontophoresis. The penetration of fluorescent ODNs in the outer nuclear layer (ONL) was quantified by image analysis of the ONL fluorescence intensity on cryosection microphotographs. Integrity of ODN was assessed using acrylamide gel migration after its extraction from the retina of treated mice. The integrity of retinal structure, 1 and 24 h after iontophoresis, was analyzed using light and electron microscopy.
Results: Transpalpebral anodal or cathodal saline iontophoresis enhanced the penetration of ODNs in all retinal layers. Cathodal iontophoresis was more efficient than anodal iontophoresis in enhancing the tissue penetration of the injected ODN. Photoreceptor delivery of ODN was significantly higher when cathodal saline transpalpebral iontophoresis was applied prior than after the injection. The extent of enhanced tissue penetration decreased in parallel to the increased interval between iontophoresis application and the intravitreous injection. Current of 1.5 mA was safe and optimal for the delivery of ODNs to the ONL. One hour after iontophoresis followed by injection, ODN extracted from the retina of treated eyes remained intact. Histology and electron microscopy observations demonstrated that iontophoresis using the optimal parameters did not induce any permanent tissue alterations or structure damage.
Conclusions: Saline transpalpebral iontophoresis facilitates the penetration of injected ODNs in photoreceptors for at least 3 h. This method may be considered for photoreceptor targeted gene therapy.
Direct iontophoresis enhances the intraocular levels of locally applied drugs, both in experimental models and in patients [1-9]. Different types of devices have been designed to apply the current on the cornea, the sclera, or both, with drug application on the eye surface in containers of various forms and materials. This type of iontophoresis procedure can be qualified as "direct ocular iontophoresis" [1-9]. More recently, direct ocular iontophoresis has also been used to enhance the intratissue and intracellular penetration of oligonucleotides (ODNs) [10-13]. The mechanisms of drug penetration facilitation by iontophoresis include electrorepulsion, electroosmosis and current-induced tissue permeation . Post-iontophoretic transport of drugs has been described in the skin and results from tissue changes that may persist for a limited period of time after current application . In order to study the penetration of ODNs into photoreceptor cells of newborn rd1/rd1 mice eyes, we have evaluated another procedure which associates electric current application at the eye surface using a saline transpalpebral iontophoresis with intravitreous injection of ODNs. Various conditions of iontophoresis (anodal versus cathodal, current intensity, and time between injection and current application) were evaluated.
C3H/HeN mice homozygous for the nonsense mutation (amino acid position 347) in the β-PDE gene (Janvier, Le Genest, France) were used (36 mice). Mice were maintained in clear plastic cages and subjected to a 12 h:12 h light-dark cycle. Experiments were conducted in accordance with the ARVO Statement for the Use of Animals in Ophthalmologic and Vision Research and the institutional guidelines regarding animal experimentation in Ophthalmic and Vision Research.
ODN was synthesized and purified by high pressure liquid chromatography by Proligo (Paris, France). A 25 mers phosphorothioate ODN, encoding for the sense wild type β-PDE gene sequence (25-6x6PS-WTS, 5'-CsCsTsTsCsCsAACCTACGTAGCAsGsAsAsAsGsT-3') and 5' labeled with hexachlorofluorescein (Hex), was used for histological evaluation of ODN distribution.
Iontophoresis and intravitreous injection
Eyelids of PN7 rd1/rd1 mice were opened with a scalpel (Swann Morton, Peynier, France) under topical tetracaine 1% drops anesthesia (Novartis Ophthalmics SA, Rueil Malmaison, France).
Transpalpebral iontophoresis system (patent number FR2830766) was used. Eye glasses shaped aluminum foil and disposable medical grade hydrophilic polyurethane sponge (3.2 mm thick, 1.5x0.7 cm length by width, Optis, Levallois, France), were soaked in phosphate buffered saline (PBS: 0.2 g/l KCl, 0.2 g/l KH2PO4, 8 g/l NaCl, 2.16 g/l Na2HPO4 7H2O, pH 7.4) and used as the active electrode (Figure 1D). The electrode covered both closed eyelids of the treated newborn mouse and the return electrode was connected to the mouse's neck (Figure 1F). An audiovisual alarm indicated any disruption of the electric circuit, ensuring a controlled delivery of the current.
Intraocular injections were carried out with ES TransferTips microcapillaries (Leica, Rueil Malmaison, France) and cut at 2 mm from their extremity, leading to a 60 μm injecting hole. Microcapillaries were linked to a Micro4TM microsyringe pump controller (World Precision instruments, Sarasota, FL). One μl of ODN (500 mM) was injected into the vitreous at a constant pressure of 200 nl/s. The position of the needle was monitored by observation with a dissecting microscope through a glass cover slip placed on the corneal surface. To limit loss of the injected solution and allow the intraocular pressure to equilibrate (as observed by the return of normal iris perfusion), the micropipette needle was left in place for 10 s after the injection before withdrawal.
The ODN distribution was evaluated 1 h after the end of the procedure. Anodal or cathodal transpalpebral saline iontophoresis (respectively, positive or negative electrode connected to the eyelids) was performed with a current of 1.5 mA for 5 min (1.43 mA/cm2) before the intravitreous injection of ODN (4 eyes for each experiment). Cathodal iontophoresis was then tested when applied immediately after the intravitreous injection of ODNs (4 eyes). The results derived from this initial set of experiments showed that cathodal iontophoresis performed prior to the intravitreal injection led to the highest ODN penetration in the ONL. This condition was therefore used to evaluate the effect of lower current intensity (0.5 mA for 5 min) or higher current intensity (2.5 mA for 5 min) as well as the duration of current-induced permeation by injecting ODN at various times after iontophoresis (acute, 1, 3 and 6 h, 4 eyes for each experiment). With the optimal conditions defined, the kinetics of fluorescent ODN distribution was evaluated at 1, 6, and 24 h after treatment (4 eyes for each condition). Control animals received intravitreous injection of 1 μl Hex (500 mM, Invitrogen, Cergy Pontoise, France) or PBS with or without previous cathodal iontophoresis (4 eyes for each condition). As additional controls, and to check the integrity of ODN after treatment, 2 mices received intravitreal ODN injection with previous iontophoresis (n=4) and sacrificed at one hour after treatment. ODN integrity, extracted from the retina, was evaluated on acrylamide gel migration. Injections were performed under topical tetracaine 1% drops anesthesia.
Mice were sacrificed by an intraperitoneal lethal dose of pentobarbital (6 g/100 ml; Ceva Santé Animale, Libourne, France). Their eyes were enucleated and processed for the various tests as described below.
Evaluation and quantification of fluorescent oligonucleotide distribution
At various times after treatment (1, 4, 6, 8, and, 24 h), the eyes were enucleated, rinsed in PBS and embedded with Tissue-Tek optimal cryotechnique compound (Bayer Diagnostics, Puteaux, France) for cryo-sectioning. Sections (10 μm) were fixed in 4% paraformaldehyde (Merck Eurolab, Strasbourg, France) for 5 min at room temperature. They were then washed in PBS, counterstained for 2 min with 1:3000 DAPI (Sigma-Aldrich, Saint-Quentin Fallavier, France), and then washed again in PBS, before being mounted in Gel Mount (Microm Microtech, Francheville, France). For localization of labeled ODN, sections were examined under a fluorescent microscope (Aristoplan, Leica), and images were captured using a digital SPOT camera (Optilas, Evry, France) with a constant exposure time of 3 s (for 2.5 times magnification) or 0.8 s (for 25 times magnification).
Five sagital sections throughout each eye were photographed for fluorescence quantification (three pictures per section, n=15 values for each eye). All pictures were taken with a 25x objective and a similar exposure time of 0.8 s. Intensity of the outer nuclear layer (ONL) fluorescence was quantified by using the luminosity feature of Photoshop. Tissue and background regions were manually selected. Mean pixel brightness was determined for each region by using the "Histogram" imaging feature. Differences in background levels among images were controlled by dividing the mean brightness level per pixel of the tissue by region the background region from each section image.
Neural retinas were dissected 1 h after intravitreous injection of Hex-labeled ODNs with prior cathodal saline iontophoresis (1.5 mA for 5 min, n=4). Pools of two retinas were placed in 500 μl of digestion buffer (50 mM Tris pH 8.0, 10 mM EDTA pH 8.0, 0.5% SDS) containing 0.5 mg/ml of proteinase K and incubated for 90 min at 56 °C. After incubation, the DNA samples were extracted once with phenol (1:1 v/v) and once with chloroform/isoamylalcohol (1:1 v/v; 24:1 v/v). The samples were then extracted once with isobutanol (1:2 v/v) and once with diethyl ether (1:1 v/v), precipitated with ethanol/ammonium acetate (1:2 v/v; 1:3 v/v), dried, resuspended in 20 μl TE buffer (10 mM Tris, pH 8; 1 mM EDTA, pH 8) and treated with DNAse1. Ten μl of each sample was denatured with 2.5 μl formamide (90% formamide, 0.05% bromophenol blue) and then run for electrophoresis on 12% denaturating polyacrylamide gel. Fluorescent Hex ODNs were visualized and photographed (Typhoon, Amersham).
Structure analysis of the retina
For structure analysis of the whole ocular globe, eyes treated with cathodal 1.5 mA iontophoresis for 5 min prior to intravitreal injection were studied. One, 6 and 24 h after the intravitreous injection, mice were sacrificed; their ocular globes were enucleated, fixed and studied (4 eyes for each condition). Cryosections at the optic nerve level were counterstained with hematoxylin and eosin, examined using a photonic Aristoplan microscope (Leica, Rueil Malmaison, France), and photographed using a digital SPOT camera (Optilas). In order to assess potential tissue changes associated with the treatment procedure, transmission electron microscopy (TEM) was performed. For this purpose, 4 eyes received iontophoresis followed by ODN injection, another 4 eyes received ODN injection without iontophoresis, and 4 other eyes received iontophoresis alone. At 1 and 24 h after treatment (2 eyes per time) the mice were sacrificed, their eyes enucleated and fixed in 2.5% glutaraldehyde of cacodylate buffer (Na 0.1 M, pH 7.4). After 1 h, globes were dissected at the limbus, the posterior eyeball post-fixed for 3 h and cut in four parts. Tissues were post-fixed in 1% osmium tetraoxyde in cacodylate buffer (Na 0.1 M, pH 7.4) and dehydrated in graduated ethanol solution (50, 70, 95, 100%). The tissues were then included in epoxy resin and oriented. Semithin sections (1 μm), obtained with an ultramicrotome Reichert Ultracut E (Leica), were stained by toluidin blue. Ultrathin sections (80 nm) were contrasted by uranyl acetate and lead citrate and observed with an electron microscope JEOL 100CX (JEOL, Tokyo, Japan) under 80 kV.
Results were expressed as means±SD and compared using the analysis of variance (ANOVA) test with post hoc Fisher test. A p<0.05 was considered significant.
Enhanced oligonucleotide delivery to retinal cells of rd1/rd1 mice
One h after the intravitreal injection of Hex-labeled WTS ODN in rd1/rd1 PN7 mice, without applied current, fluorescence was observed in the nuclei of the ganglion cell layer (GCL) and in the most superficial nuclei of the inner nuclear layer (INL; Figure 1A,B, inset). No fluorescence was detected in the ONL (Figure 1A,B). One hour after intravitreous injection of the fluorochrome (Hex) alone, diffuse fluorescence was observed in the vitreous and in cells of the INL but without specific accumulation in the cell nuclei (Figure 1C, inset).
When saline iontophoresis (Figure 1D-F) was applied and immediately followed by injection of the labeled ODN, intense fluorescence was observed in all retinal layers (Figure 1G,H). Specific localization to the retinal cell nuclei was seen in these cases (inset Figure 1G). When saline iontophoresis was applied and followed immediately by the injection of the fluorochrome (Hex) alone (without ODN), diffuse fluorescence was observed in all retinal layers (Figure 1I). However, this fluorescence was not accumulating specifically in the cell nuclei (inset in Figure 1I). No fluorescence was observed in the retinal layers of PBS-treated eyes (Figure 1J,L) or non-injected control eyes (with or without saline iontophoresis, data not shown; 4 eyes for each condition).
ODN integrity was confirmed by acrylamide gel electrophoresis of the DNA extracted from retinas of treated eyes 1 h after iontophoresis followed by injection (data not shown).
Effect of iontophoretic parameters on oligonucleotide penetration
We have chosen to perform iontophoresis prior to ODN injection in order to limit the risk of infection and of potential reflux of ODNs from the globe by mechanical pressure of the probe on the eyelids. Cathodal or anodal iontophoresis (1.5 mA for 5 min) prior to the intravitreous injection of ODNs showed that the application of current enhanced ODN penetration when compared to injection without iontophoresis (p<0.05) or no treatment (Figure 2). Furthermore, prior cathodal saline iontophoresis significantly enhanced ODN penetration in the ONL cells when compared to anodal saline iontophoresis (p<0.001). Performing cathodal saline iontophoresis immediately prior to the intravitreous ODN injection significantly enhanced the ODN penetration in ONL when compared to application of cathodal iontophoresis immediately following ODN injection (p<0.001). From all tested conditions, cathodal iontophoresis performed immediately prior to ODN injection yielded the highest ODN penetration in the ONL of treated mice eyes. The latter condition was therefore used to evaluate further parameters.
Effect of current intensity
Iontophoresis with 0.5 mA significantly decreased the ODN penetration in ONL when compared to 1.5 mA (p<0.05), showing that ODN penetration in the ONL depends on the amount of applied current (Figure 3). Increasing the current intensity to 2.5 mA (for 5 min) induced electric skin burns and pain (data not shown). This condition was therefore not further studied.
Duration of postiontophoretic facilitation of ODN penetration
The postiontophoretic enhancement of ODN penetration decreased with the increased interval between iontophoresis and injection. Facilitation of ODN penetration in the ONL was highest with the shortest interval, during at least 3 h, and vanished when ODN injection was performed 6 h after saline iontophoresis (Figure 4). These results demonstrate that the iontophoresis facilitation of intraretinal penetration is temporary.
Kinetics of oligonucleotide distribution in the retina
Using optimal treatment parameters (cathodal iontophoresis 1.5 mA for 5 min prior to intravitreous injection), we observed most intense ONL fluorescence 1 h after the ODN injection, decreasing rapidly at later times (Figure 5). Indeed, already at 4 and 6 h after treatment, we noted that fluorescence was decreasing in the outer retina (Figure 5B,C). At 8 h, ODN fluorescence remained only in the GCL (Figure 5D), and no fluorescence is observed in the neuroretina at 24 h (Figure 5E). This kinetic suggests that Hex-labeled ODNs may be rapidly degraded after their retinal penetration.
Light and electron microscopy observations
The ocular gross histology structure was not affected by the iontophoresis application. No lesion or cell damage was detected at 1 h (Figure 6A,D), 6 h (Figure 6B,E), or 24 h (Figure 6C,F) after treatment.
Analysis of semithin sections revealed that 1 h after application of saline iontophoresis, internuclear spaces within the INL and ONL were increased. Linear enlargements can be followed from the outer rows of the INL up to the external limiting membrane. This localization is suggestive of retinal Müller glial cell (RMG) prolongations. Note that nuclei in the INL and the ONL have normal structures and do not show any signs of apoptosis or necrosis (Figure 7D,E). No such changes were observed in untreated control retinas or in eyes without current application (Figure 7A-C). Twenty four h after iontophoresis application, internuclear spacing was no longer observed and the ONL had regained a normal architecture (Figure 7G).
TEM analysis showed that in eyes receiving injection without electric current applied or in untreated control eyes, the retinas retained a normal structure without any detectable changes (Figure 8A,B). Eyes analyzed 1 h after iontophoretic current application demonstrated enlargement of RMG prolongations (Figure 8C, arrow) with normal integrity of the photoreceptor nuclei. At 24 h after iontophoresis, treated eyes were found to no longer have enlargement of RMG prolongation (Figure 8E). Thus the observed RMG changes induced by the electric current were temporary and it was evident that no permanent ultra-structure change was induced by the optimal iontophoresis parameters used in this study. Particularly, no alteration of photoreceptors could be detected.
Our results show that the application of transpalpebral saline iontophoresis enhances ODN penetration into photoreceptors of newborn mice eyes. The facilitation and enhancement of penetration were associated with the intensity of the current. In this study, we determined that a 1.5 mA (1.43 mA/cm2) current applied for 5 min is efficient and safe for newborn mice eyes. No structural damage of the treated eyes was observed, and the normal architecture of the retina was preserved using these iontophoresis parameters in newborn (PN7) mice. For direct ocular iontophoresis, the active electrode is in contact with the drug solution and electrorepulsion is thought to facilitate the penetration of drug in ocular tissues . However, electrorepulsion is responsible only for a part of the current effect, as facilitated diffusion of noncharged molecules can also be achieved . Electroosmosis is another mechanism of drug penetration acting through a flow process (vol/distance/time). Electroosmosis-induced drug penetration is particularly important for larger molecules [14,18,19]. Increased "passive" permeability for a limited period of time after the application of current was also observed in the skin [15,20]. In these experiments, it was demonstrated that the slow recovery of skin impedance following iontophoresis was due to the movement of ions in response to electric field and that the resulting postiontophoretic enhanced-diffusion was not associated with damage to the skin barrier . Application of saline iontophoresis before the local instillation of phenylephrine increased the observed vasoconstriction effect of this drug . Most of the studies elucidating the different mechanisms of iontophoresis drug penetration and facilitation have been conducted on the skin. The results obtained by our present study show that saline iontophoresis also influences the permeability of intraocular tissues to charged molecules such as ODNs. It is not clear why iontophoresis prior to intraviteous injection is more efficient than if the current is applied after injection. One hypothesis is that when iontophoresis is applied after intravitreous injection, potential extraocular diffusion of the injected ODNs due to the mechanical pressure may be responsible for this observed phenomenon. Additional experiments using different conditions and parameters are being carried out to provide more clues regarding these results.
The ODNs used in this study were negatively charged and had a molecular weight of 7591 g/mol. These characteristics can allow them to penetrate through the internal limiting membrane. However, the exact mechanisms responsible for the transport from the inner retina to the photoreceptor cells remain poorly understood. Such transport is probably highly regulated and does not follow passive diffusion. Simple direct vitreous injection of ODNs does not lead to their penetration into photoreceptor nuclei. On the other hand, when saline iontophoresis is performed with the intravitreous injection of ODNs, labeling of the ONL is observed. This labeling may reflect internalization. In our study, the only changes observed in the retina using semithin histology were enlarged linear spaces observed from the outer rows of the INL up to the external limiting membrane at one hour after saline iontophoresis. The localization of these spaces may indicate that changes have occurred in RMG prolongations. Interestingly, this phenomenon was reversible since it could not be observed at 24 h after the application of current. One hypothesis may be that RMG cells could participate in the increased penetration of ODN in the photoreceptors. Increased transport vacuoles were observed in the corneal epithelium when direct constant current iontophoresis was applied . This effect was temporary and lasted only for a few hours. In the present study, we have observed reversal to normal retinal ultrastructure (without persistent enlargement of RMG elongations) 24 h after the current application.
As shown in our experiments, a rapid loss of fluorescence suggested that rapid degradation of phosphorothioate 25-mers ODN occurs in the retina. For gene correction or other purpose, additional modification of short single-stranded or double-stranded RNA or DNA such as methylation of ribose hydroxyl groups or use of morpholino replacement of the ribose phosphate backbone may significantly prolong the half-life of ODN in the retina [24,25].
In conclusion, we have demonstrated that saline iontophoresis prior to intravitreous injection of ODNs facilitates the migration of these charged molecules and enhances their penetration into the retina photoreceptors. Postiontophoretic enhancement of charged molecules is therefore demonstrated in the retina. Whether prior saline iontophoresis can also facilitate the intraretinal penetration of larger size ODN molecules or plasmids remains to be explored.
Charlotte Andrieu-Soler is funded by Optis France and the French Ministry of Research and Education. This work was supported by the GenHomme program from the French Ministry for Research and Education (grants 2001 number 01 H 0203, 2002 number 01 H 0204), the "fondation de l'avenir" (grant ET4 378) and the Craft project (grant QLK6-CT-2002-71548)B.
1. Lachaud JP. [Considerations on the use of corticoids by ionization in certain ocular diseases]. Bull Soc Ophtalmol Fr 1965; 65:84-9.
2. Hughes L, Maurice DM. A fresh look at iontophoresis. Arch Ophthalmol 1984; 102:1825-9.
3. Barza M, Peckman C, Baum J. Transscleral iontophoresis of gentamicin in monkeys. Invest Ophthalmol Vis Sci 1987; 28:1033-6.
4. Rootman DS, Jantzen JA, Gonzalez JR, Fischer MJ, Beuerman R, Hill JM. Pharmacokinetics and safety of transcorneal iontophoresis of tobramycin in the rabbit. Invest Ophthalmol Vis Sci 1988; 29:1397-401.
5. Lam TT, Edward DP, Zhu XA, Tso MO. Transscleral iontophoresis of dexamethasone. Arch Ophthalmol 1989; 107:1368-71.
6. Sarraf D, Equi RA, Holland GN, Yoshizumi MO, Lee DA. Transscleral iontophoresis of foscarnet. Am J Ophthalmol 1993; 115:748-54.
7. Behar-Cohen F, El Aouni A, Le Rouic JF, Parel JM, Renard G, Chauvaud D. [Iontophoresis: past and future]. J Fr Ophtalmol 2001; 24:319-27.
8. Behar-Cohen FF, El Aouni A, Gautier S, David G, Davis J, Chapon P, Parel JM. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels. Exp Eye Res 2002; 74:51-9.
9. Halhal M, Renard G, Courtois Y, BenEzra D, Behar-Cohen F. Iontophoresis: from the lab to the bed side. Exp Eye Res 2004; 78:751-7.
10. Voigt M, de Kozak Y, Halhal M, Courtois Y, Behar-Cohen F. Down-regulation of NOSII gene expression by iontophoresis of anti-sense oligonucleotide in endotoxin-induced uveitis. Biochem Biophys Res Commun 2002; 295:336-41.
11. Berdugo M, Valamanesh F, Andrieu C, Klein C, Benezra D, Courtois Y, Behar-Cohen F. Delivery of antisense oligonucleotide to the cornea by iontophoresis. Antisense Nucleic Acid Drug Dev 2003; 13:107-14.
12. Asahara T, Shinomiya K, Naito T, Shiota H. Induction of gene into the rabbit eye by iontophoresis: preliminary report. Jpn J Ophthalmol 2001; 45:31-9.
13. Davies JB, Ciavatta VT, Boatright JH, Nickerson JM. Delivery of several forms of DNA, DNA-RNA hybrids, and dyes across human sclera by electrical fields. Mol Vis 2003; 9:569-78 <http://www.molvis.org/molvis/v9/a69/>.
14. Guy RH, Kalia YN, Delgado-Charro MB, Merino V, Lopez A, Marro D. Iontophoresis: electrorepulsion and electroosmosis. J Control Release 2000; 64:129-32.
15. Santi P, Nicoli S, Colombo G, Bettini R, Artusi M, Rimondi S, Padula C, Rizzo P, Colombo P. Post-iontophoresis transport of ibuprofen lysine across rabbit ear skin. Int J Pharm 2003; 266:69-75.
16. Li SK, Jeong EK, Hastings MS. Magnetic resonance imaging study of current and ion delivery into the eye during transscleral and transcorneal iontophoresis. Invest Ophthalmol Vis Sci 2004; 45:1224-31.
17. Li SK, Higuchi WI, Kochambilli RP, Zhu H. Mechanistic studies of flux variability of neutral and ionic permeants during constant current dc iontophoresis with human epidermal membrane. Int J Pharm 2004; 273:9-22.
18. Marro D, Kalia YN, Delgado-Charro MB, Guy RH. Contributions of electromigration and electroosmosis to iontophoretic drug delivery. Pharm Res 2001; 18:1701-8.
19. Kalia YN, Naik A, Garrison J, Guy RH. Iontophoretic drug delivery. Adv Drug Deliv Rev 2004; 56:619-58.
20. Kim A, Green PG, Rao G, Guy RH. Convective solvent flow across the skin during iontophoresis. Pharm Res 1993; 10:1315-20.
21. Curdy C, Kalia YN, Guy RH. Post-iontophoresis recovery of human skin impedance in vivo. Eur J Pharm Biopharm 2002; 53:15-21.
22. Drummond PD. Prior iontophoresis of saline enhances vasoconstriction to phenylephrine and clonidine in the skin of the human forearm. Br J Clin Pharmacol 2002; 54:45-50.
23. Behar-Cohen FF, Parel JM, Pouliquen Y, Thillaye-Goldenberg B, Goureau O, Heydolph S, Courtois Y, De Kozak Y. Iontophoresis of dexamethasone in the treatment of endotoxin-induced-uveitis in rats. Exp Eye Res 1997; 65:533-45.
24. Summerton J, Weller D. Morpholino antisense oligomers: design, preparation, and properties. Antisense Nucleic Acid Drug Dev 1997; 7:187-95.
25. Allerson CR, Sioufi N, Jarres R, Prakash TP, Naik N, Berdeja A, Wanders L, Griffey RH, Swayze EE, Bhat B. Fully 2'-modified oligonucleotide duplexes with improved in vitro potency and stability compared to unmodified small interfering RNA. J Med Chem 2005; 48:901-4.